Keywords: India, Compulsory licensing, Bayerm Nexavar, Natco Pharma, Intellectual property, MSF

Indian hearings on Bayer Nexavar compulsory license delayed

Article | 22 August 2012

India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical major Bayer (BAYB: DE) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Natco Pharma

Go to company listing

Related Drugs

Nexavar

Go to drug listing